| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 9.5e-05 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -6.4e-05 | 1 |